US · Healthcare

American Oriental Bioengineering Inc (AOBI)

Biotechnology

American Oriental Bioengineering Inc (AOBI) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AOBI

P/E ratio

18.00

American Oriental Bioengineering Inc (AOBI) — FAQ

What is AOBI's P/E ratio?

The price-to-earnings (P/E) ratio for American Oriental Bioengineering Inc (AOBI) is 18.00 (data as of 2026-03-23).

Does American Oriental Bioengineering Inc pay a dividend?

Dividend yield is not available in the current snapshot for American Oriental Bioengineering Inc (AOBI). Check the MyAverix Finance app for the latest dividend data.

What sector is American Oriental Bioengineering Inc in?

American Oriental Bioengineering Inc (AOBI) is classified in the Healthcare sector (Biotechnology industry).

What exchange is AOBI listed on?

AOBI is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)